Pushkal Garg
EVP Chief R&D · 4 filings · Latest: Mar 4, 2026
ALNYLAM PHARMACEUTICALS, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ALNY | Pushkal Garg | EVP Chief R&D | Mar 5, 2026 | Sale | $323.96 | 2,404 | $778.8K | 18,693 | |
ALNY | Pushkal Garg | EVP Chief R&D | Mar 4, 2026 | Sale | $323.08 | 2,309 | $746.0K | 21,097 | |
ALNY | Garg Pushkal | — | Mar 5, 2026 | Proposed Sale | $323.69 | 2,404 | $778.2K | — | |
ALNY | Pushkal Garg | EVP Chief R&D | Mar 3, 2026 | Sale | $319.74 | 1,775 | $567.5K | 23,406 | |
ALNY | Pushkal Garg | EVP Chief R&D | Mar 2, 2026 | Sale | $327.66 | 1,717 | $562.6K | 25,181 | |
ALNY | Garg Pushkal | — | Mar 3, 2026 | Proposed Sale | $321.37 | 1,775 | $570.4K | — | |
ALNY | Pushkal Garg | EVP Chief R&D | Feb 27, 2026 | Sale | $331.34 | 4,627 | $1.5M | 22,129 | |
ALNY | Pushkal Garg | EVP Chief R&D | Feb 27, 2026 | Option Exercise | $0.00 | 1,908 | — | 26,756 | |
ALNY | Garg Pushkal | — | Feb 27, 2026 | Proposed Sale | $331.34 | 4,627 | $1.5M | — | |
ALNY | Pushkal Garg | EVP Chief R&D | Feb 13, 2026 | Sale | $310.08 | 2,242 | $695.2K | 24,848 | |
ALNY | Garg Pushkal | — | Oct 3, 2025 | Proposed Sale | $451.00 | 3,022 | $1.4M | — | |
ALNY | Garg Pushkal | — | Aug 19, 2025 | Proposed Sale | $457.00 | 1,455 | $664.9K | — | |
ALNY | Garg Pushkal | — | Mar 24, 2025 | Proposed Sale | $300.00 | 5,445 | $1.6M | — | |
ALNY | Garg Pushkal | — | Mar 21, 2025 | Proposed Sale | $285.00 | 4,321 | $1.2M | — | |
ALNY | Garg Pushkal | — | Mar 4, 2025 | Proposed Sale | $241.09 | 808 | $194.8K | — | |
ALNY | Garg Pushkal | — | Mar 3, 2025 | Proposed Sale | $246.18 | 973 | $239.5K | — | |
ALNY | Garg Pushkal | — | Feb 18, 2025 | Proposed Sale | $256.95 | 1,548 | $397.8K | — | |
ALNY | Garg Pushkal | — | Jan 27, 2025 | Proposed Sale | $285.00 | 52,592 | $15.0M | — | |
ALNY | Garg Pushkal | — | Dec 12, 2024 | Proposed Sale | $255.02 | 1,752 | $446.8K | — |